ADIAL PHARMACEUTICALS CEO William Stilley's 2018 pay jumps 232% to $1.2M

ADIAL PHARMACEUTICALS reports 2018 executive compensation

By ExecPay News

Published: July 8, 2019

ADIAL PHARMACEUTICALS reported fiscal year 2018 executive compensation information on July 8, 2019.
In 2018, two executives at ADIAL PHARMACEUTICALS received on average a compensation package of $760K, a 183% increase compared to previous year.
Average pay of disclosed executives at ADIAL PHARMACEUTICALS
William B. Stilley, Chief Executive Officer, received $1.2M in total, which increased by 232% compared to 2017. 82% of Stilley's compensation, or $988K, was in option awards. Stilley also received $181K in salary and $42K in other compensation.
Joseph A. M. Truluck, Chief Financial Officer, received a compensation package of $308K, which increased by 79% compared to previous year. 72% of the compensation package, or $223K, was in option awards.

Related executives

William Stilley

ADIAL PHARMACEUTICALS

Chief Executive Officer

Joseph Truluck

ADIAL PHARMACEUTICALS

Chief Financial Officer

You may also like

Source: SEC filing on July 8, 2019.